Pless v. Secretary of Health and Human Services

CourtUnited States Court of Federal Claims
DecidedMarch 3, 2017
Docket16-271
StatusUnpublished

This text of Pless v. Secretary of Health and Human Services (Pless v. Secretary of Health and Human Services) is published on Counsel Stack Legal Research, covering United States Court of Federal Claims primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Pless v. Secretary of Health and Human Services, (uscfc 2017).

Opinion

In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS No. 16-271V Filed: February 6, 2017 Not for Publication

************************************* SUSAN PLESS, * * Petitioner, * * v. * Tetanus-diphtheria-acellular pertussis * (“Tdap”) vaccine; paresthesias, GBS, SECRETARY OF HEALTH * somatoform disorder; no expert; AND HUMAN SERVICES, * motion for decision dismissing petition * Respondent. * * ************************************* Michael G. McLaren, Memphis, TN, for petitioner. Amy P. Kokot, Washington, DC, for respondent.

MILLMAN, Special Master

DECISION 1

On February 26, 2016, petitioner filed a petition under the National Childhood Vaccine Injury Act, 42 U.S.C. § 300aa-10-34 (2012), alleging that at some indeterminate time 2 after 1 Because this unpublished decision contains a reasoned explanation for the special master’s action in this case, the special master intends to post this unpublished decision on the United States Court of Federal Claims’ website, in accordance with the E-Government Act of 2002, 44 U.S.C. § 3501 note (2012) (Federal Management and Promotion of Electronic Government Services). Vaccine Rule 18(b) states that all decisions of the special masters will be made available to the public unless they contain trade secrets or commercial or financial information that is privileged and confidential, or medical or similar information whose disclosure would constitute a clearly unwarranted invasion of privacy. When such a decision is filed, petitioner has 14 days to identify and move to redact such information prior to the document’s enclosure. If the special master, upon review, agrees that the identified material fits within the banned categories listed above, the special master shall redact such material from public access. 2 In her affidavit, petitioner alleges she had tingling in her lower extremities, muscle aches, and joint pain on June 22, 2014. Ex. 1, at 2. In her VAERS report, petitioner, after mistaking the date of her vaccination as March 30, 2014, gives an onset date of June 13, 2011 for pain behind her right eye, paresthesias in her face followed a few days later by pain in her toe and tingling and numbness extending up her leg, spine, and back of her head, giving her blurred vision, difficulty turning her eye, weakness in both legs and arms, burning pain in her legs and spine, slurred speech, and difficulty chewing. Ex. 29, at 1. receiving tetanus-diphtheria-acellular pertussis (“Tdap”) on May 30, 2014, she had chronic paresthesias, 3 weakness, Guillain-Barré syndrome (“GBS”), 4 somatoform disorder, 5 and neuropathy. Pet. Preamble.

The Federal Circuit in Capizzano v. Secretary of Health and Human Services emphasized that the special masters are to evaluate seriously the opinions of petitioner’s treating doctors since “treating physicians are likely to be in the best position to determine whether a logical sequence of cause and effect show[s] that the vaccination was the reason for the injury.” 440 F.3d 1317, 1326 (Fed. Cir. 2006); see also Broekelschen v. Sec’y of HHS, 618 F.3d 1339, 1347 (Fed. Cir. 2010); Andreu v. Sec’y of HHS, 569 F.3d 1367, 1375 (Fed. Cir. 2009). No doctors in this case attribute any of petitioner’s multiple complaints of GBS or any neurological or immunological disease within two months of her May 30, 2014 Tdap vaccination.

The undersigned ruled in Corder v. Sec’y of HHS, No. 08-228V, 2011 WL 2469736 (Fed. Cl. Spec. Mstr. May 31, 2011), that flu vaccine cannot cause GBS after two months following vaccination. In Corder, the onset interval was four months. In the instant action, the medical records during the period from May 30, 2014 (vaccination) to July 30, 2014 show repeated examinations of petitioner resulted in a normal neurologic diagnosis. One cannot have GBS with normal reflexes, normal strength, normal CSF protein count, and normal nerve conduction and EMG studies.

On September 26, 2016, the undersigned issued an Order to Show Cause why this case

3 Paresthesia is “an abnormal touch sensation. . . .” Dorland’s Illustrated Medical Dictionary 1383 (32d ed. 2012) (hereinafter, “Dorland’s”). 4 GBS “begins with paresthesias of the feet, followed by flaccid paralysis of the entire lower limbs, ascending to the trunk, upper limbs, and face; other characteristics include slight fever, bulbar palsy, absent or lessened tendon reflexes, and increased protein in the cerebrospinal fluid without a corresponding increase in cells.” Dorland’s at 1832. 5 Somatoform disorder denotes “physical symptoms that cannot be attributed to organic disease and appear to be of psychic origin.” Dorland’s at 1734. Petitioner was receiving psychotherapy for generalized anxiety disorder before her vaccination. Med. recs. Ex. 28, at 23-63 (dating from May 24, 2011 to March 4, 2014). For instance, on May 29, 2012, petitioner told her therapist that her anxiety had been significantly worse and she had been waking with extreme anxiety and panic attacks in the middle of the night. Id. at 50. She said that she woke up and was shaky all day and wanted to shut down for the entire afternoon. Id. The therapist focused on the importance of petitioner not focusing on all the negatives. Id. Petitioner’s first psychotherapy visit after her May 30, 2014 Tdap vaccination was April 1, 2014 and concerned family stresses. Id. at 22. Her second psychotherapy visit after her May 30, 2014 Tdap vaccination was June 3, 2014 and also concerned family stresses. Id. at 21. Her third psychotherapy visit after her May 30, 2014 Tdap vaccination was June 17, 2014 and concerned family and work stresses. Id. at 20. Only at her fourth psychotherapy visit on July 29, 2013, two months after her May 30, 2014 Tdap vaccination, did she tell her psychotherapist about her dog biting her on the nose and face, and her having pressure in her eyes, numbness and weakness in her legs and in her muscles in her legs and arm. Id. at 18. She said she had experienced severe migraine headaches and vision difficulties consisting of blurring. Id. Petitioner said she had seen numerous doctors and felt very overwhelmed and frustrated because they dismissed her symptoms as being the result of anxiety. Id. 2 should not be dismissed.

On October 6, 2016, the undersigned held a telephonic status conference with counsel, during which petitioner’s counsel said he had retained Dr. Michael Hilton to review the case. The undersigned issued an Order setting a deadline of December 5, 2016 for petitioner to file an expert report.

On December 5, 2016, petitioner moved for an extension of time of 60 days to file an expert report which the undersigned granted, setting a new deadline of February 3, 2017.

On February 3, 2017, petitioner filed a Motion for a Decision Dismissing the Petition. Petitioner states in her motion that she “has been unable to secure sufficient and/or persuasive evidence to prove entitlement to compensation in the Vaccine Program.” Mot. at ¶ 1. She also states that “to proceed further would be unreasonable and would waste the resources of the Court, Respondent, Petitioner, and the Vaccine Program.” Id. at ¶ 2.

The undersigned GRANTS petitioner’s motion and DISMISSES this case.

FACTS

Medical Records

On May 30, 2014, petitioner saw nurse practitioner Geovanna O.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
Pless v. Secretary of Health and Human Services, Counsel Stack Legal Research, https://law.counselstack.com/opinion/pless-v-secretary-of-health-and-human-services-uscfc-2017.